The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 17, 2026
Dividend Yield: 1.44%
Dividend Frequency: quarterly
Years of Dividend History: 28
The State Street Health Care Select Sector SPDR ETF dividend gives investors focused exposure to healthcare companies within the S&P 500, spanning pharmaceuticals, biotechnology, medical equipment, and healthcare providers. XLV currently yields 1.89%, with a trailing annual dividend rate of $3.1748 per share paid quarterly. The next ex-dividend date is September 21, 2026, with the most recent quarterly payment of $0.6422 per share. A beta of 0.51 makes this fund notably less volatile than the broader market, which suits growth-and-income investors who can accept a low current yield in exchange for above-average dividend growth.
State Street Health Care Select Sector SPDR ETF pays out dividends as a pass-through fund, making a traditional payout ratio not applicable (fund/ETF). State Street Health Care Select Sector SPDR ETF dividend safety is tied directly to the income generated by its underlying holdings across pharmaceuticals, biotechnology, and healthcare services, rather than a single company's earnings. The primary pressure point is that distributions fluctuate with the dividend activity of those underlying S&P 500 healthcare constituents, which means the fund's payout is not insulated from sector-wide dividend cuts.
State Street Health Care Select Sector SPDR ETF dividend history shows a CAGR of 10.2% per year from 2010 to 2025. Per-share payments grew from $0.5770 to $2.4766 over that period (2026 is a partial year and excluded from this calculation). The largest annual increase in the window was 61.9% in 2019, though the data also contains at least one year-over-year decline exceeding 5%, so growth has not been linear.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +7.5% | $1.99 (2022) | $2.48 (2025) |
| 5-Year | +7.9% | $1.69 (2020) | $2.48 (2025) |
| 10-Year | +9.1% | $1.03 (2015) | $2.48 (2025) |
XLV fits growth-and-income investors who want healthcare sector exposure and prioritize dividend growth over current income. The yield is low (below 2%), and at 1.89% it sits well above the fund's 5-year average of 1.28%, which means the current entry point offers a historically elevated yield for this fund. Five consecutive years of dividend increases back the growth story, and a 10.2% CAGR over 15 years is a meaningful rate for a diversified sector ETF. The trade-off is straightforward: investors get strong historical dividend growth and low market volatility (beta of 0.51), but the current yield alone will not satisfy investors who need substantial income today.
| Payment Date | Amount per Share |
|---|---|
| 2026-09-21 | $0.6422 |
| 2026-06-22 | $0.6562 |
| 2026-03-23 | $0.5947 |
| 2025-12-22 | $0.6568 |
| 2025-09-22 | $0.6249 |
| 2025-06-23 | $0.6304 |
| 2025-03-24 | $0.5645 |
| 2024-12-23 | $0.6217 |
| 2024-09-23 | $0.5772 |
| 2024-06-24 | $0.5725 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.8932 |
| 2025 | $2.4766 |
| 2024 | $2.2942 |
| 2023 | $2.1687 |
| 2022 | $1.9925 |
Project income from XLV with the XLV dividend calculator or track your full portfolio with the dividend tracker.